トップ > 製品検索結果一覧 > Code No. D271-4 Anti-CD8 (Mouse) mAb-FITC

Code No. D271-4

Anti-CD8 (Mouse) mAb-FITC

価格(税別)

¥25,000

在庫

10以上

(2019/12/10 00:05時点)

包装

1 mL (100 tests)

データ
  • Flow Cytometry

クローナリティー Monoclonal クローン KT15
アイソタイプ
(免疫動物)
Rat IgG2aλ
使用法
FCM
10 µL (Ready for use.)  
免疫原(抗原) T cell clone C6, H-2Kk restricted H-Y antigen specific CTL
交差性
[Gene ID]

Mouse[12525]

性状 PBS/1% BSA/0.1% ProClin 150
保存温度 4°C 標識 FITC メーカー MBL
背景 The CD8 antigen is a cell surface glycoprotein found on most cytotoxic T lymphocytes that mediates efficient cell-cell interactions within the immune system. The CD8 antigen, acting as a coreceptor, and the T cell receptor on the T lymphocyte recognize antigen displayed by an antigen presenting cell in the context of class I MHC molecules. The functional coreceptor is either a homodimer composed of two α chains, or a heterodimer composed of one α and one β chain. Both α and β chains share significant homology to immunoglobulin variable light chains. CD8 α chains bind to class-I MHC molecules α3 domains. CD8 identifies cytotoxic/suppressor T-cells that interact with MHC class I bearing targets. CD8 is thought to play a role in the process of T-cell mediated killing.This monoclonal antibody KT15 reacts with a non-polymorphic epitope on the mouse CD8 α chain (mouse Ly2.1 and Ly2.2 cells).
関連製品 D271-A64 Anti-CD8 (Mouse) mAb-Alexa Fluor® 647
D341-4 Anti-CD4 (Mouse) mAb-FITC
M090-4 Rat IgG2b (isotype control)-FITC
D271-5 Anti-CD8 (Mouse) mAb-PE
M081-4 Rat IgG2a (isotype control)-FITC
使用文献
使用文献募集中!本製品を使って論文を発表されましたら是非お知らせください。

Flow Cytometry

  1. Asano J et al. Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo. J. Immunol. 184, 736-45 (2010)(PMID:20008287)
  2. Kayamuro H et al. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus. J. Virol. 84, 12703-12 (2010)(PMID:20881038)
  3. Nobuoka D et al. Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy. Cancer Immunol Immunother. 62, 639-52 (2013)(PMID:23143746)
  4. Ohyagi H et al. Monocyte-derived dendritic cells perform hemophagocytosis to fine-tune excessive immune responses. Immunity 39, 584-98 (2013)(PMID:24035363)
  5. Sawada Y et al. Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes. Int J Oncol. 46, 28-36 (2015)(PMID:25354479)
  6. Toyota H et al. Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivo. Oncol Rep. 33, 292-6 (2015)(PMID:25394516)
  7. Kamimura D et al. Strong TCR-mediated signals suppress integrated stress responses induced by KDELR1 deficiency in naive T cells. Int Immunol. 28, 117-26 (2016)(PMID:26489882)
  8. Uematsu T et al. Loss of CARD9-mediated innate activation attenuates severe influenza pneumonia without compromising host viral immunity. Sci Rep. 5, 17577 (2015)(PMID:26627732)
  9. Matsueda S et al. Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte-specific protein tyrosine kinase. Cancer Sci. 109, 611-617 (2018)(PMID:29388341)
  10. Ouchi Y et al. Generation of tumor antigen-specific murine CD8+ T cells with enhanced anti-tumor activity via highly efficient CRISPR/Cas9 genome editing. Int Immunol. 30, 141-154 (2018)(PMID:29617862)
  11. Kim JW et al. A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model. Mol Ther Oncolytics. 5, 97-104 (2017)(PMID:28573184)
  12. Matsuo H et al. CD11c-specific bio-nanocapsule enhances vaccine immunogenicity by targeting immune cells. J Nanobiotechnology 16, 59 (2018)(PMID:30077180)
  13. Nagamata S et al. Identification of CD4 and H-2Kd-restricted cytotoxic T lymphocyte epitopes on the human herpesvirus 6B glycoprotein Q1 protein. Sci Rep. 9, 3911 (2019) (PMID:30846739)
製品
カテゴリー
分野
免疫
細胞膜表面抗原
この製品に関するお問い合わせをする

※在庫につきましては2019年12月10日 00時05分時点における在庫数を表示してあります。
※価格の赤色表示につきましては、キャンペーン価格の表示となっております。
※このサイトからは直接注文はできません。ご注意ください。
※使用法の表記について:
WB: Western Blotting, IH: Immunohistochemistry, IC: Immunocytochemistry, IP: Immunoprecipitation,
FCM: Flow Cytometry NT: Neutralization, IF: Immunofluorescence, RIP: RNP Immunoprecipitation,
ChIP: Chromatin Immunoprecipitation, CoIP: Co-Immunoprecipitation
DB: Dot Blotting, NB: Northern Blotting, RNA FISH: RNA Fluorescence in situ hybridization
※使用法・交差性の表記について:
*: 論文で報告されております(MBLでは未確認)。詳しくはデータシートをご覧ください。
**: 導入元からの情報です(MBLでは評価中もしくは未確認)。
※保存温度の表記について: RT: 室温
※本サイトの掲載製品は、品質改良のため予告なく仕様などの変更、または販売中止となる場合がございます。あらかじめご了承ください。